文献速递运动医学关节外科

英国生物银行研究:退行性肩袖疾病手术风险的新遗传标记

Identification of a Novel Genetic Marker for Risk of Degenerative Rotator Cuff Disease Surgery in the UK Biobank.
PubMed 文献 · J Bone Joint Surg Am · 2021-01-01

基于英国生物银行50万人前瞻性队列,纳入2917例退行性肩袖疾病手术病例和14158名匹配对照,全基因组关联分析发现CREB5基因rs2237352与手术风险相关(OR=1.17,95%CI 1.11-1.24)。未重复既往报道的位点,需影像学确诊研究验证。

要点

  • CREB5基因rs2237352与退行性肩袖疾病手术风险相关,OR=1.17。
  • 该位点常见(次要等位基因频率47%),填补置信度高(info score=0.9847)。
  • 未发现既往报道的肩袖疾病相关位点达全基因组显著。

核心结论

  • CREB5基因变异与退行性肩袖疾病手术风险存在新关联。

研究设计与样本

  • 基于英国生物银行50万人前瞻性队列,纳入欧洲 ancestry 无三级以内亲缘关系的个体。
  • 病例为ICD-10编码M75.1且接受肩袖疾病相关手术者,排除同次就诊有创伤诊断者。
  • 每个病例按年龄、性别和随访时间匹配至多5名对照。

主要发现

  • 共识别2917例肩袖疾病手术病例和14158名匹配对照。
  • 发现1个全基因组显著信号(p < 5 × 10-8),位于7号染色体CREB5基因,标记为rs2237352(OR=1.17,95%CI 1.11-1.24)。
  • rs2237352 imputed 置信度高(info score=0.9847),次要等位基因频率47%。
  • 扩大对照样本纳入额外非匹配非病例后,rs2237352和CREB5基因另一SNP rs12700903均达全基因组显著。
  • 未检测到既往研究中与肩袖疾病相关位点的全基因组显著信号。

关键数值与推荐

  • 全基因组显著性阈值p < 5 × 10-8。
  • 病例定义:ICD-10编码M75.1由创伤/骨科专家确定且手术与肩袖疾病治疗一致。
  • 排除标准:同次就诊期间诊断创伤性损伤。

临床怎么用

  • 遗传易感标记有助于理解肩袖退变的生物学过程。
  • 可在临床中辅助评估肩袖疾病风险,但需进一步验证。

局限性

  • 需在具备影像学数据以确认诊断的研究中验证该发现。
  • 证据等级为预后Level III。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: While evidence indicates that familial predisposition influences the risk of developing degenerative rotator cuff disease (RCD), knowledge of specific genetic markers is limited. We conducted a genome-wide association study of RCD surgery using the UK Biobank, a prospective cohort of 500,000 people (40 to 69 years of age at enrollment) with genotype data. METHODS: Cases with surgery for degenerative RCD were identified using linked hospital records. The cases were defined as an International Classification of Diseases, Tenth Revision (ICD-10) code of M75.1 determined by a trauma/orthopaedic specialist and surgery consistent with RCD treatment. Cases were excluded if a diagnosis of traumatic injury had been made during the same hospital visit. For each case, up to 5 controls matched by age, sex, and follow-up time were chosen from the UK Biobank. Analyses were limited to European-ancestry individuals who were not third-degree or closer relations. We used logistic regression to test for genetic association of 674,405 typed and >10 million imputed markers, after adjusting for age, sex, population principal components, and follow-up. RESULTS: We identified 2,917 RCD surgery cases and 14,158 matched controls. We observed 1 genome-wide significant signal (p < 5 × 10-8) for a novel locus tagged by rs2237352 in the CREB5 gene on chromosome 7 (odds ratio [OR] = 1.17, 95% confidence interval [CI] = 1.11 to 1.24). The single-nucleotide polymorphism (SNP) rs2237352 was imputed with a high degree of confidence (info score = 0.9847) and is common, with a minor allele frequency of 47%. After expanding the control sample to include additional unmatched non-cases, rs2237352 and another SNP in the CREB5 gene, rs12700903, were genome-wide significant. We did not detect genome-wide significant signals at loci associated with RCD in previous studies. CONCLUSIONS: We identified a novel association between a variant in the CREB5 gene and RCD surgery. Validation of this finding in studies with imaging data to confirm diagnoses will be an important next step. CLINICAL RELEVANCE: Identification of genetic RCD susceptibility markers can guide understanding of biological processes in rotator cuff degeneration and help inform disease risk in the clinical setting. LEVEL OF EVIDENCE: Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Yanik EL, Keener JD, Lin SJ, et al. Identification of a Novel Genetic Marker for Risk of Degenerative Rotator Cuff Disease Surgery in the UK Biobank. J Bone Joint Surg Am. 2021. PMID: 33979311. doi:10.2106/JBJS.20.01474

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。